Wilkinson A L, Pedersen S H, Urassa M, Michael D, Andreasen A, Todd J, Kinung'hi S M, Changalucha J, McDermid J M
Division of Nutritional Sciences, Cornell University, Ithaca, NY, USA.
National Institute for Medical Research, Mwanza Research Centre, Mwanza, Tanzania.
Trop Med Int Health. 2017 Jan;22(1):52-62. doi: 10.1111/tmi.12799. Epub 2016 Nov 9.
HIV infection is associated with chronic systemic inflammation, with or without antiretroviral therapy. Consequences for foetal growth are not understood, particularly in settings where multiple maternal infections and malnutrition are common. The study was designed to examine maternal systemic circulating and umbilical cord blood cytokine concentrations in relation to birth anthropometry in a Tanzanian prospective cohort.
A 9-plex panel of maternal plasma cytokines in HIV-positive (n = 44) and HIV-negative (n = 70) mothers and the same cytokines in umbilical cord blood collected at delivery was assayed. Linear regression modelled associations between maternal or cord blood cytokines and birth anthropometry.
Health indicators (haemoglobin, mid-upper-arm circumference, body mass index) in HIV-positive mothers without considerable immunosuppression did not differ from HIV-negative women. Despite this, HIV-exposed infants had lower birthweight and length. Subgroup analyses indicated that HIV management using HAART was associated with lower plasma TNF-α, as were longer durations of any antiretroviral therapy (≥2 months). Greater maternal plasma TNF-α was associated with earlier delivery (-1.7 weeks, P = 0.039) and lower birthweights (-287 g; P = 0.020), while greater umbilical cord TNF-α (-1.43 cm; P = 0.036) and IL-12p70 (-2.4 cm; P = 0.008) were associated with shorter birth length. Birthweight was inversely associated with cord IL-12p70 (-723 g; P = 0.001) and IFN-γ (-482 g, P = 0.007). Maternal cytokines during pregnancy did not correlate with umbilical cord cytokines at delivery.
Systemic inflammation identified in maternal plasma or umbilical cord blood was associated with poorer birth anthropometrics in HIV-exposed and HIV-unexposed infants. Controlling maternal and/or foetal systemic inflammation may improve birth anthropometry.
无论是否接受抗逆转录病毒治疗,HIV感染都与慢性全身炎症相关。其对胎儿生长的影响尚不清楚,尤其是在多种孕产妇感染和营养不良常见的环境中。本研究旨在检测坦桑尼亚一个前瞻性队列中,孕产妇全身循环和脐带血细胞因子浓度与出生人体测量学指标之间的关系。
检测了HIV阳性母亲(n = 44)和HIV阴性母亲(n = 70)血浆中的9种细胞因子,并在分娩时检测了脐带血中的相同细胞因子。采用线性回归模型分析孕产妇或脐带血细胞因子与出生人体测量学指标之间的关联。
免疫抑制不严重的HIV阳性母亲的健康指标(血红蛋白、上臂中部周长、体重指数)与HIV阴性女性无差异。尽管如此,暴露于HIV的婴儿出生体重和身长较低。亚组分析表明,使用高效抗逆转录病毒治疗(HAART)管理HIV与较低的血浆肿瘤坏死因子-α(TNF-α)相关,任何抗逆转录病毒治疗持续时间较长(≥2个月)时也是如此。孕产妇血浆中较高的TNF-α与早产(-1.7周,P = 0.039)和较低的出生体重(-287 g;P = 0.020)相关,而脐带血中较高的TNF-α(-1.43 cm;P = 0.036)和白细胞介素-12p70(IL-12p70,-2.4 cm;P = 0.008)与较短的出生身长相关。出生体重与脐带血IL-12p70(-723 g;P = 0.001)和干扰素-γ(IFN-γ,-482 g,P = 0.007)呈负相关。孕期孕产妇细胞因子与分娩时脐带血细胞因子无相关性。
孕产妇血浆或脐带血中发现的全身炎症与暴露于HIV和未暴露于HIV的婴儿较差的出生人体测量学指标相关。控制孕产妇和/或胎儿全身炎症可能会改善出生人体测量学指标。